| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.03 | 0.5 |